Addressing Challenges Of Ophthalmic Product Filling

By John Erdner, Portfolio Manager for Fill-Finish, SP Industries and Alex Armengol, International Senior Sales director, SP i-Dositecno

Many ophthalmic diseases and eye irritations are treated with topically administered drug products. However, whereas early production environments were unclassified, the ophthalmic industry has changed dramatically over the years, and these operations now fall under regulatory scrutiny, so filling operations must be accomplished in cleanrooms with controlled environments.

Innovative pharmaceutical packaging formats are being developed to meet the growing requirement for sterile, safe and secure packaging and delivery of ophthalmic products. Due to the diversity of these sterile ophthalmic medications, aseptic filling lines must be highly sophisticated and adaptable to address a variety of packaging challenges in this growing market.